Hempcin Advanced Topical Pain Relief Cream

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended dosage is to apply the medication externally to the affected area no more than 3 to 4 times daily.

In the case of children under 2 years of age, it is advised to consult a healthcare professional prior to administration.

Contraindications

Use is contraindicated in patients who may apply the product in large quantities, particularly over raw surfaces or blistered areas, due to the potential for adverse effects. Additionally, exceeding the recommended doses is contraindicated unless specifically directed by a healthcare professional.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes and to refrain from applying the product to wounds or damaged skin. Bandaging should not be done tightly, and the cap of the tube must be secured tightly after use. The product should be stored at room temperature, away from heat sources. Caution is advised against using large quantities, particularly over raw surfaces or blistered areas. The recommended doses should not be exceeded unless specifically directed by a healthcare professional.

Healthcare providers should instruct patients to discontinue use and seek medical advice if any of the following occur: an allergic reaction, worsening of the condition, lack of improvement within 7 days, symptoms that resolve but then return within a few days, or any unusual effects that may arise.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients using this product may experience a range of adverse reactions, which can be categorized based on seriousness and frequency.

Serious adverse reactions include allergic reactions, which necessitate immediate cessation of use and consultation with a healthcare provider. Patients are advised to stop using the product and seek medical attention if they experience any signs of an allergic reaction, if their condition worsens or fails to improve within 7 days, if symptoms resolve but then return within a few days, or if they notice any unusual effects.

Common side effects associated with the use of this product primarily relate to its application. It is important to note that this product is for external use only and should not come into contact with the eyes. Patients should avoid applying the product to wounds or damaged skin and should not bandage the area tightly after application. Additionally, large quantities should not be used, particularly over raw surfaces or blistered areas, and the recommended doses should not be exceeded unless directed by a healthcare professional.

Patients should also be aware of the importance of proper storage; the cap of the tube should be tightly secured, and the product should be stored at room temperature away from heat sources.

In the event of accidental ingestion, it is crucial to keep the product out of the reach of children and to seek medical help or contact a Poison Control Center immediately if swallowed.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Hempcin Advanced Topical Pain Relief Cream (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication externally to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

There is no specific information regarding the use of HEMPCIN Advanced Topical Pain Relief Cream in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution when considering the use of this product in patients aged 65 and older, as individual patient factors may necessitate careful monitoring and assessment.

Pregnancy

There is no specific information regarding the use of HEMPCIN Advanced Topical Pain Relief Cream in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for use during pregnancy. Therefore, healthcare professionals should exercise caution when considering this product for women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable to discuss the use of this product with pregnant patients, considering the lack of data on its safety during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of HEMPCIN Advanced Topical Pain Relief Cream in lactating mothers. Additionally, there is no information available concerning the potential for excretion of the product in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. Healthcare professionals are advised to instruct patients or caregivers to seek medical help or contact a Poison Control Center without delay if the substance has been ingested.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment and appropriate management strategies should be implemented based on clinical presentation and available guidelines.

It is imperative that healthcare providers remain vigilant and prepared to initiate supportive care and symptomatic treatment as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Healthcare providers should instruct patients to discontinue use and consult a doctor if any of the following occur: an allergic reaction, worsening of the condition, lack of improvement within 7 days, symptoms that resolve but then return within a few days, or any unusual effects.

When using this product, patients must be cautioned against applying it in large quantities, especially on raw surfaces or blistered areas. Additionally, they should not exceed the recommended doses unless specifically directed by a healthcare professional.

Storage and Handling

The product is supplied in a tightly capped tube. It should be stored at room temperature, ensuring it is kept away from heat sources to maintain its integrity and efficacy.

Additional Clinical Information

Patients should apply the medication externally to the affected area no more than 3 to 4 times daily. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Hempcin Advanced Topical Pain Relief Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)